ARTICLE
6 September 2018

European Securities And Markets Authority Intends To Extend Product Intervention Measures For Binary Options For A Further Three Months

AO
A&O Shearman

Contributor

A&O Shearman was formed in 2024 via the merger of two historic firms, Allen & Overy and Shearman & Sterling. With nearly 4,000 lawyers globally, we are equally fluent in English law, U.S. law and the laws of the world’s most dynamic markets. This combination creates a new kind of law firm, one built to achieve unparalleled outcomes for our clients on their most complex, multijurisdictional matters – everywhere in the world. A firm that advises at the forefront of the forces changing the current of global business and that is unrivalled in its global strength. Our clients benefit from the collective experience of teams who work with many of the world’s most influential companies and institutions, and have a history of precedent-setting innovations. Together our lawyers advise more than a third of NYSE-listed businesses, a fifth of the NASDAQ and a notable proportion of the London Stock Exchange, the Euronext, Euronext Paris and the Tokyo and Hong Kong Stock Exchanges.
On August 24, 2018, the European Securities and Markets Authority announced its intention to adopt a Decision to extend the prohibition on the marketing, distribution and sale of binary options ...
European Union Corporate/Commercial Law

On August 24, 2018, the European Securities and Markets Authority announced its intention to adopt a Decision to extend the prohibition on the marketing, distribution and sale of binary options to retail investors for a further three-month period from October 2, 2018. ESMA has previously adopted intervention measures for binary options, with the current Decision set to expire on October 1, 2018.

ESMA has power under the Markets in Financial Instruments Regulation to impose prohibitions or restrictions on certain financial instruments, financial activities or practices. This may be done when, among other conditions, the exercise of ESMA's power addresses a significant investor protection concern in the Union. Product intervention measures imposed by ESMA under MiFIR must be reviewed at appropriate intervals and at least every three months. If a measure is not renewed after three months, it will expire. In reviewing the current Decision, ESMA has agreed to exclude from the scope of product intervention certain types of binary option that are less likely to lead to a significant investor protection concern.

The types of binary options that will be excluded from the scope of the new Decision after October 2018 are:

  • a binary option for which the lower of the two predetermined fixed amounts is at least equal to the total payment made by a retail client for the binary option, including any commissions, transaction fees and other related costs; and
  • a binary option that meets cumulatively the following three conditions: (i) the term from issuance to maturity is at least ninety calendar days; (ii) a prospectus drawn up and approved in accordance with the Prospectus Directive is available to the public; and (iii) the binary option does not expose the provider to market risk throughout the term of the binary option and the provider or any of its group entities do not make a profit or loss from the binary option, other than previously disclosed commissions, transaction fees or other related charges.

ESMA's Board of Supervisors agreed on the renewal of intervention measures on August 22, 2018. ESMA will publish an official notice on its website in the coming weeks. The new Decision will then be published in the Official Journal of the EU and will start to apply from October 2, 2018 for a period of three months.

The ESMA press release is available at: https://www.esma.europa.eu/sites/default/files/library/esma71-99-1026_-_esma_to_renew_prohibition_on_binary_options_for_a_further_three_months.pdf  and the ESMA's Decision published in June 2018 is available at: https://finreg.shearman.com/european-securities-and-markets-authority-extend.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More